secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProMIS Neurosciences Inc. (PMN)
CIK:        0001374339
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001558370-23-011879
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProMIS Neurosciences continues from CBCA into Ontario under OBCA
----------------------------------------------------------------

- Continuance effective July 13, 2023; approved by shareholders on June 29, 2023.
- Company now governed by Ontario Business Corporations Act; CBCA no longer applies.
- No change in business, headquarters, management, assets, or Nasdaq/TSX listing.
- OBCA has no director residency requirement; short selling by insiders not prohibited.
- Shareholder rights generally comparable; some differences in dissent and oppression remedies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374339/000155837023011879/0001558370-23-011879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374339/000155837023011879/pmn-20230713x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer